Literature DB >> 18191978

Nef enhances HIV-1 infectivity via association with the virus assembly complex.

Mingli Qi1, Christopher Aiken.   

Abstract

The HIV-1 accessory protein Nef enhances virus infectivity by facilitating an early post-entry step of infection. Nef acts in the virus producer cell, leading to a beneficial modification to HIV-1 particles. Nef itself is incorporated into HIV-1 particles, where it is cleaved by the viral protease during virion maturation. To probe the role of virion-associated Nef in HIV-1 infection, we generated a fusion protein consisting of the host protein cyclophilin A (CypA) linked to the amino terminus of Nef. The resulting CypA-Nef protein enhanced the infectivity of Nef-defective HIV-1 particles and was specifically incorporated into the virions via association with Gag during particle assembly. Pharmacologic or genetic inhibition of CypA-Nef binding to Gag prevented incorporation of CypA-Nef into virions and inhibited infectivity enhancement. Our results indicate that infectivity enhancement by Nef requires its association with a component of the assembling HIV-1 particle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191978      PMCID: PMC2440657          DOI: 10.1016/j.virol.2007.12.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  73 in total

1.  Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

Authors:  C Aiken
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain.

Authors:  C H Lee; K Saksela; U A Mirza; B T Chait; J Kuriyan
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

3.  Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.

Authors:  T R Gamble; F F Vajdos; S Yoo; D K Worthylake; M Houseweart; W I Sundquist; C P Hill
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

4.  The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.

Authors:  S Swingler; P Gallay; D Camaur; J Song; A Abo; D Trono
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  Solution structure of a polypeptide from the N terminus of the HIV protein Nef.

Authors:  K J Barnham; S A Monks; M G Hinds; A A Azad; R S Norton
Journal:  Biochemistry       Date:  1997-05-20       Impact factor: 3.162

6.  Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.

Authors:  M W Pandori; N J Fitch; H M Craig; D D Richman; C A Spina; J C Guatelli
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease.

Authors:  A A Bukovsky; T Dorfman; A Weimann; H G Göttlinger
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions.

Authors:  T Dorfman; A Weimann; A Borsetti; C T Walsh; H G Göttlinger
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.

Authors:  D Braaten; E K Franke; J Luban
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.

Authors:  R Welker; H Kottler; H R Kalbitzer; H G Kräusslich
Journal:  Virology       Date:  1996-05-01       Impact factor: 3.616

View more
  22 in total

1.  Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.

Authors:  Nadine Laguette; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

2.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

3.  The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.

Authors:  Birthe Trautz; Virginia Pierini; Rebecka Wombacher; Bettina Stolp; Amanda J Chase; Massimo Pizzato; Oliver T Fackler
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

4.  Interaction between Nef and INI1/SMARCB1 augments replicability of HIV-1 in resting human peripheral blood mononuclear cells.

Authors:  Dohun Pyeon; In-Woo Park
Journal:  Arch Virol       Date:  2015-01-07       Impact factor: 2.574

5.  Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Authors:  Christelle Brégnard; Alessia Zamborlini; Marjorie Leduc; Philippe Chafey; Luc Camoin; Ali Saïb; Serge Benichou; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

6.  Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.

Authors:  Shailendra K Saxena; Gaurav Shrivastava; Sneham Tiwari; Ml Arvinda Swamy; Madhavan Pn Nair
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

7.  Inhibition of HIV-1 infection and replication by enhancing viral incorporation of innate anti-HIV-1 protein A3G: a non-pathogenic Nef mutant-based anti-HIV strategy.

Authors:  Linden A Green; Ying Liu; Johnny J He
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

8.  HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells.

Authors:  Metka Lenassi; Gerard Cagney; Maofu Liao; Tomaz Vaupotic; Koen Bartholomeeusen; Yifan Cheng; Nevan J Krogan; Ana Plemenitas; B Matija Peterlin
Journal:  Traffic       Date:  2010-01       Impact factor: 6.215

9.  Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1.

Authors:  Matthew P Morrow; Angela Grant; Zahedi Mujawar; Larisa Dubrovsky; Tatiana Pushkarsky; Yana Kiselyeva; Lucas Jennelle; Nigora Mukhamedova; Alan T Remaley; Fatah Kashanchi; Dmitri Sviridov; Michael Bukrinsky
Journal:  Mol Pharmacol       Date:  2010-05-17       Impact factor: 4.436

10.  Virus-producing cells determine the host protein profiles of HIV-1 virion cores.

Authors:  Steven Santos; Yuri Obukhov; Sergei Nekhai; Michael Bukrinsky; Sergey Iordanskiy
Journal:  Retrovirology       Date:  2012-08-13       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.